Effects of Budesonide and Fluticasone Propionate in Pediatric Asthma Patients

Effects of Budesonide and Fluticasone Propionate in Pediatric Asthma Patients

Cytokines and chemokines play important roles in asthma. However, little information exists on the effects of inhaled corticosteroids on cytokine and chemokine plasma levels in childhood asthma. We compared the pharmaceutical effects of two inhaled corticosteroids used in pediatric patients with mil...

Full description

Bibliographic Details
Main Authors:	Lin-Yu Kuo, Chih-Hsing Hung, Hsing-I Tseng, Jiunn-Ren Wu, Yuh-Jyh Jong, Yu-Te Chu
Format:	Article
Language:	English
Published:	Elsevier 2010-02-01
Series:	Pediatrics and Neonatology
Subjects:	asthma budesonide chemokine cytokine exhaled NO fluticasone
Online Access:	http://www.sciencedirect.com/science/article/pii/S1875957210600071

Similar Items

Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
by: Belchamber KBR, et al.
Published: (2018-09-01)

Nongenomic Effects of Fluticasone Propionate and Budesonide on Human Airway Anion Secretion
by: Hasegawa, Yoshinori, et al.
Published: (2012)

Effect of Switching from Salmeterol/Fluticasone to Formoterol/Budesonide Combinations in Patients with Uncontrolled Asthma
by: Taisuke Akamatsu, et al.
Published: (2012-01-01)

A Comparison of Long-Term Anti-Inflammatory Effect of Two ICS/LABA Combination Inhalers; Fix-Dosed Maintenance Therapy with Budesonide/Formoterol and Salmeterol/Fluticasone
by: Masayuki Hojo, et al.
Published: (2014-01-01)

Effects of Salmeterol and Fluticasone Propionate Combination versus Fluticasone Propionate on Airway Function and Eosinophilic Inflammation in Mild Asthma
by: Makoto Hoshino, et al.
Published: (2009-01-01)

Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial
by: Furuhashi K, et al.
Published: (2019-09-01)

Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients Without Optimally Controlled asthma (REACT) Study [Corrigendum]
by: Cheng SL, et al.
Published: (2021-02-01)

Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study
by: Cheng SL, et al.
Published: (2020-12-01)

Comparison of Effectiveness in Ciclesonide and Fluticasone Propionate on Small Airway Function in Mild Asthma
by: Makoto Hoshino
Published: (2010-01-01)

The Clinical Evaluation of the Acceptance of Fluticasone Propionate Diskus® by Older Japanese Patients with Bronchial Asthma
by: Hiroyuki Ohbayashi
Published: (2005-01-01)

The comparison of fluticasone propionate/formoterol with fluticasone propionate/salmeterol for paediatric asthma: a meta-analysis of randomized controlled trials
by: Xiaofen Jin, et al.
Published: (2020-01-01)

Assessment of Bone Density in Children 6 to 14 Years Old with Asthma Treated with Fluticasone
by: I Mohammadzadeh, et al.
Published: (2017-06-01)

Optimal step-down approach for pediatric asthma controlled by salmeterol/fluticasone: A randomized, controlled trial (OSCAR study)
by: Kenichi Akashi, et al.
Published: (2016-07-01)

Step-down therapy in well-controlled asthmatic patients using salmeterol xinafoate/fluticasone propionate combination therapy
by: Horiuchi K, et al.
Published: (2016-03-01)

Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study
by: Jean Bousquet, et al.
Published: (2017-04-01)

Asthma Control Can Be Maintained after Fixed-Dose, Budesonide/Formoterol Combination Inhaler Therapy is Stepped Down from Medium to Low Dose
by: Masayuki Hojo, et al.
Published: (2013-01-01)

Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma
by: Bernstein David I, et al.
Published: (2011-12-01)

Beneficial Immunomodulatory Effects of Fluticasone Propionate in <i>Chlamydia pneumoniae</i>-Infected Mice
by: Dóra Paróczai, et al.
Published: (2021-03-01)

Effects of budesonide inhalation and montelukast on airway function and serum inflammatory factors in children with asthma
by: Li Huang, et al.
Published: (2018-01-01)

Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting
by: Perrone V, et al.
Published: (2016-11-01)

Inhaled budesonide for adults with mild-to-moderate asthma: a randomized placebo-controlled, double-blind clinical trial
by: Ana Luisa Godoy Fernandes, et al.
Published: (2001-09-01)

Pharmacoeconomic aspects of bronchial asthma therapy: real clinical practice
by: A. S. Belevsky, et al.
Published: (2018-10-01)

Effects of budesonide combined with gubenkechuan capsules on related factors in patients with bronchial asthma
by: Jian-Bo Chen, et al.
Published: (2018-09-01)

Cost-effectiveness of budesonide Turbuhaler in the treatment of mild-to-moderate asthma in Japan
by: Terumasa Miyamoto, et al.
Published: (1999-01-01)

Fluticasone propionate and increased risk of pneumonia in COPD: is it PAFR-dependent?
by: Sohal SS
Published: (2017-12-01)

Pharmaceutical Benefits of Fluticasone Propionate Association to Delivery Systems: In Vitro and In Vivo Evaluation
by: Marina G. Dogbe, et al.
Published: (2019-10-01)

Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
by: Tsan-Ming Huang, et al.
Published: (2020-09-01)

The Effectiveness of Budesonide Nasal Irrigation After Endoscopic Sinus Surgery in Chronic Rhinosinusitis With Asthma
by: Tae Wook Kang, et al.
Published: (2017-03-01)

The efficacy of fluticasone propionate nebulizer therapy in children with laryngotracheitis
by: Лариса Михайлівна Станіславчук
Published: (2015-08-01)

Exposure-Response and Clinical Outcome Modeling of Inhaled Budesonide/Formoterol Combination in Asthma Patients
by: Hyun-moon Back, et al.
Published: (2020-04-01)

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD
by: Janson C, et al.
Published: (2017-10-01)

Nebulized Budesonide vs. Placebo in Adults with Asthma Attack; a Double Blind Randomized Placebo-Controlled Clinical Trial
by: Hojat Sheikh-Motahar-Vahedi, et al.
Published: (2018-12-01)

Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma
by: Woodcock Ashley, et al.
Published: (2011-12-01)

Efficacy of fluticasone propionate ointment 0.005% in childhood lichen planus
by: Abhinav Kumar, et al.
Published: (2020-01-01)

Comparative Study of Topical Treatment in Allergic Rhinitis Using Azelastine and Fluticasone in a Combination Verses Fluticasone Propionate Alone
by: Raisha G. Dalvi, et al.
Published: (2019-04-01)

In vitro Antibacterial Activity of Mometasone Furoate, Fluticasone Propionate and Fluticasone Furoate Nasal Preparations Against Streptococcus pneumoniae, Hemophilus influenzae, Streptococcus viridans, Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli
by: Philip Lance A. Liu, et al.
Published: (2010-06-01)

Degradation rates and products of fluticasone propionate in alkaline solutions
by: Tadakazu Tokumura, et al.
Published: (2017-10-01)

Fluticasone propionate for external use: pharmacological properties and clinical effectiveness
by: E. V. Dvoriankova
Published: (2021-06-01)

Caregiver treatment satisfaction is improved together with children's asthma control: Prospective study for budesonide monotherapy in school-aged children with uncontrolled asthma symptoms
by: Shigemi Yoshihara, et al.
Published: (2015-10-01)

Preparation of nanosized Fluticasone Propionate nasal spray with improved stability and uniformity
by: Dai Jiajia, et al.
Published: (2015-01-01)